New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 22, 2014
06:32 EDTNUVANuVasive upgraded to Outperform from Market Perform at Leerink
Leerink upgraded NuVasive citing the company's improved operational performance and upside to consensus estimates. The firm raised its price target for shares to $45 from $33.
News For NUVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 5, 2015
10:20 EDTNUVAHigh option volume stocks
Subscribe for More Information
May 4, 2015
19:14 EDTNUVAOn The Fly: After Hours Movers
UP AFTER EARNINGS: Nautilus (NLS), up 15.5%... EarthLink (ELNK), up 9.3%... Chuy's Holdings (CHUY), up 8.4%... ChannelAdvisor (ECOM), up 6.8% after reporting quarterly results and appointing David Spitz as CEO... Texas Roadhouse (TXRH), up 5.3%... NuVasive (NUVA), up 3.8%... Denny's (DENN), up 1.8%. ALSO HIGHER: PlasmaTech (PTBI), up 37.1% after Soros Fund Management reports 5.17% passive stake... Integrated Silicon Solution (ISSI), up 1.6% after Starboard raises stake to 11.5% from 9.9%. DOWN AFTER EARNINGS: Qualys (QLYS), down 27.1%... FreightCar America (RAIL), down 9%... InvenSense (INVN), down 2.9%... Sturm, Ruger (RGR), down 6.1%. ALSO LOWER: AcelRx (ACRX), down 27.4% after FDA denies request for meeting about Zalviso... Cyberark (CYBR), down 3.6% following Qualys quarterly results.
16:22 EDTNUVANuVasive backs FY15 adjusted EPS $1.10, consensus $1.11
Subscribe for More Information
16:19 EDTNUVANuVasive reports Q1 adjusted EPS 30c, consensus 22c
Subscribe for More Information
April 30, 2015
07:53 EDTNUVANuVasive has buyout potential with OIG overhang removed, says Brean Capital
Subscribe for More Information
April 29, 2015
11:08 EDTNUVAPiper says recent moves could fuel NuVasive takeover talk
Piper Jaffray believes the settlement with the Department of Health and Human Services, coupled with the recent CEO and COO departures, could fuel speculation of a takeover for NuVasive (NUVA). Piper, however, thinks investors are focused on the company's 2015 revenue guidance, which it views as attainable. It keeps an Overweight rating on NuVasive, saying the OIG settlement removes an overhang.
08:55 EDTNUVANuVasive settlement removes an overhang, says Wells Fargo
Wells Fargo believes the settlement NuVasive reached with the Department of Justice removes an overhang on the stock and that the $13.8M fine is "relatively immaterial." Wells notes NuVasive will likely not be subject to a corporate integrity agreement which it says would have increased expenses. It expects shares to move higher on the news and keeps an Outperform rating on the name.
08:20 EDTNUVANuVasive reaches agreement in principle to settle OIG matter
Subscribe for More Information
April 27, 2015
08:10 EDTNUVANuVasive weakness creates buying opportunity, says RBC Capital
Subscribe for More Information
April 22, 2015
10:17 EDTNUVAHigh option volume stocks

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use